pharma · Juvenile Neuronal Ceroid Lipofuscinosis · PLYX
Polaryx Therapeutics
Polaryx Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Paramus, USA HQ
2014 Founded
9 Employees
Public company Type
PLYX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Paramus, USA
- Founded
- 2014
- Employees
- 9
- Programs
- 1
- Drugs
- 0
- Patents
- 0
Polaryx Therapeutics pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Polaryx Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.